Springworks Therapeutics Inc (SWTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Springworks Therapeutics Inc-Aktie (SWTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	285.64% 21.01	5.447	-	-	-
Cost Of Revenue	1.202	-	-	-	-
Gross Profit	19.80	-	-	-	-
Operating Expenses	9.90% 113.73	103.49	84.00	82.85	77.70
Benefits Costs and Expenses	114.94	-	-	-	-
Costs And Expenses	114.94	-	-	-	-
Operating Income/Loss	4.60% -93.93	-98.46	-84.00	-82.85	-77.70
Nonoperating Income/Loss	26.69% 7.571	5.976	5.586	5.828	5.557
Income/Loss Before Equity Method Investments	15.84% -92.91	-110.40	-78.41	-77.02	-72.14
Income/Loss From Equity Method Investments	44.14% -1.025	-1.835	-1.024	-0.901	-1.278
Income/Loss From Continuing Operations Before Tax	16.31% -93.93	-112.23	-79.44	-77.92	-73.42
Income/Loss From Continuing Operations After Tax	7.35% -87.39	-94.32	-79.44	-77.92	-73.42
Net Income/Loss	7.35% -87.39	-94.32	-79.44	-77.92	-73.42
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	9,903% 73.77	0.7374	62.52	62.46	62.33
Diluted Average Shares	9,903% 73.77	0.7374	62.52	62.46	62.33
Basic Earnings Per Share	18.62% -1.18	-1.45	-1.27	-1.25	-1.18
Diluted Earnings Per Share	18.62% -1.18	-1.45	-1.27	-1.25	-1.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%